Pulse Biosciences (PLSE) Share-based Compensation (2015 - 2025)

Pulse Biosciences' Share-based Compensation history runs 11 years deep, the most recent figure standing at $5.0 million for Q4 2025.

• In Q4 2025, Share-based Compensation fell 26.84% year-over-year to $5.0 million; the TTM figure through Dec 2025 stood at $21.5 million (up 57.93% YoY), while the FY2025 annual figure was $21.5 million, up 57.93% from the prior year.
• Share-based Compensation was $5.0 million for Q4 2025 at Pulse Biosciences, down from $5.6 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $6.8 million in Q4 2024 to a low of $723000.0 in Q3 2022.
• Historically, Share-based Compensation has averaged $3.0 million across 5 years, with a median of $2.2 million in 2021.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation slumped 79.29% in 2022, then surged 347.06% in 2023.
• A 5-year view of Share-based Compensation shows it stood at $3.6 million in 2021, then plunged by 79.29% to $748000.0 in 2022, then soared by 347.06% to $3.3 million in 2023, then soared by 103.14% to $6.8 million in 2024, then declined by 26.84% to $5.0 million in 2025.
• The last three Share-based Compensation figures came in at $5.0 million (Q4 2025), $5.6 million (Q3 2025), and $5.2 million (Q2 2025), per Business Quant data.